| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | SEQIRUS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$430,000 | |
| 2026 | SEQIRUS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$280,000 | |
| 2025 | SEQIRUS |
3rd Quarter (July 1 - Sep 30) AMENDED |
$400,000 | |
| 2025 | SEQIRUS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$250,000 | |
| 2025 | SEQIRUS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$250,000 | |
| 2025 | SEQIRUS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$260,000 | |
| 2025 | SEQIRUS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$250,000 | |
| 2024 | SEQIRUS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$220,000 | |
| 2024 | SEQIRUS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$370,000 | |
| 2024 | SEQIRUS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$200,000 |
| Firm | Filings | Expenses |
|---|---|---|
| SEQIRUS | 46 | $7,240,000 |
| Issue | Activities |
|---|---|
| Budget/Appropriations | 43 |
| Health Issues | 20 |
| Medical/Disease Research/Clinical Labs | 3 |
| Science/Technology | 1 |
| Disaster Planning/Emergencies | 1 |
| Manufacturing | 1 |